Trial Profile
Comparison of the Efficacy and Safety of Paclitaxel-Eluting CoroflexTM Please Stent Versus Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2013
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms PIPA
- 05 Apr 2011 Results presented at the 60th Annual Scientific Session of the American College of Cardiology.
- 17 Aug 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 17 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.